Beida Pharmaceuticals: The time for shareholders holding more than 5% of the shares to reduce their holdings has expired, with a cumulative reduction of 1.0756% of the shares.

Peking University Medicine announced that the time for the shareholder Peking University Medical Holding (holding more than 5% of the shares) to reduce its holdings has expired. The original plan was to reduce no more than 17,879,622 shares, accounting for 3% of the total share capital, from October 14, 2025 to January 11, 2026. Due to its own funding needs, Peking University Medical reduced 6,410,774 shares, accounting for 1.0756% of the total share capital, through centralized bidding and block trading from October 22, 2025 to January 11, 2026. After the reduction, Peking University Medical holds 63,918,175 shares, accounting for 10.7247% of the total share capital. This reduction is not in violation of regulations and does not affect the company's control rights and continuous operation.